{"recordsFiltered":48523,"recordsTotal":48523,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=34500","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=33900","results":[{"registry_id":"NCT06780306","publication_url":"https://clinicaltrials.gov/study/NCT06780306","title":"A Phase 2 Randomized, Controlled, Multicenter, Dose Optimization Study of TTAX03 in the Treatment of Mild to Moderate Dry Eye Disease (DED)","has_exemption":false,"start_date":"2024-12-12","completion_date":"2026-01-30","has_results":false,"results_due":false,"sponsor_name":"BioTissue Holdings, Inc","sponsor_slug":"biotissue-holdings-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06721962","publication_url":"https://clinicaltrials.gov/study/NCT06721962","title":"A Phase 1/2a, Open Label, Dose Escalation Study to Evaluate the Safety and Preliminary Efficacy of TRX103 in Subjects With Moderate to Severe Treatment-Refractory Crohn's Disease","has_exemption":false,"start_date":"2025-05-05","completion_date":"2026-01-30","has_results":false,"results_due":false,"sponsor_name":"Tr1X, Inc.","sponsor_slug":"tr1x-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07223996","publication_url":"https://clinicaltrials.gov/study/NCT07223996","title":"Use of In-Home Non-Stress Monitoring Device for Fetal Monitoring: A Nonsignificant Risk (NSR) Device Study","has_exemption":false,"start_date":"2025-09-30","completion_date":"2026-01-30","has_results":false,"results_due":false,"sponsor_name":"Nestmedic Spolka Akcyjna","sponsor_slug":"nestmedic-spolka-akcyjna","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221461","publication_url":"https://clinicaltrials.gov/study/NCT07221461","title":"Prospective, Single Center, Open-label Study Assessing Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality and Biomarkers in Patients on Glucagon-like Peptide-1 Agonists","has_exemption":false,"start_date":"2025-11-01","completion_date":"2026-01-30","has_results":false,"results_due":false,"sponsor_name":"Goldman, Butterwick, Fitzpatrick and Groff","sponsor_slug":"goldman-butterwick-fitzpatrick-and-groff","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05652465","publication_url":"https://clinicaltrials.gov/study/NCT05652465","title":"An Open Trial of Transcranial Magnetic Stimulation for Youth With Treatment-Resistant Major Depressive Disorder","has_exemption":false,"start_date":"2026-01-15","completion_date":"2026-01-30","has_results":false,"results_due":false,"sponsor_name":"National Institute of Mental Health (NIMH)","sponsor_slug":"national-institute-of-mental-health-nimh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02947750","publication_url":"https://clinicaltrials.gov/study/NCT02947750","title":"Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease","has_exemption":false,"start_date":"2016-10-31","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02922894","publication_url":"https://clinicaltrials.gov/study/NCT02922894","title":"Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury","has_exemption":false,"start_date":"2017-06-09","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"John D. Dingell VA Medical Center","sponsor_slug":"john-d-dingell-va-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02962557","publication_url":"https://clinicaltrials.gov/study/NCT02962557","title":"Detecting Post-surgical Respiratory Compromise and Prompting Patients to Self-rescue: An Early Feasibility Study","has_exemption":false,"start_date":"2017-10-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03348995","publication_url":"https://clinicaltrials.gov/study/NCT03348995","title":"A Prospective Cohort Clinical Trial Evaluating Age as a Risk Factor for Poor Outcomes of Bridge-Enhanced ACL Restoration (BEAR)","has_exemption":false,"start_date":"2018-04-17","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Miach Orthopaedics","sponsor_slug":"miach-orthopaedics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04016870","publication_url":"https://clinicaltrials.gov/study/NCT04016870","title":"Project My Heart Your Heart: Prospective Evaluation of the Safety and Efficacy of Cardiac Pacemaker Reuse in Low to Middle Income Countries","has_exemption":false,"start_date":"2018-10-13","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03601455","publication_url":"https://clinicaltrials.gov/study/NCT03601455","title":"Phase II Study of Radiation Therapy and Anti-PD-L1 Checkpoint Inhibitor (Durvalumab) With or Without Anti-CTLA-4 Inhibition (Tremelimumab) in Patients With Unresectable, Locally Advanced, or Metastatic Urothelial Bladder Cancer That Are Ineligible or Refusing Chemotherapy","has_exemption":false,"start_date":"2018-10-26","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03219307","publication_url":"https://clinicaltrials.gov/study/NCT03219307","title":"Safety and Efficacy of NOVOCART 3D in the Treatment of Articular Cartilage Defects Following Failure on Microfracture","has_exemption":false,"start_date":"2018-11-30","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Aesculap Biologics, LLC","sponsor_slug":"aesculap-biologics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03652753","publication_url":"https://clinicaltrials.gov/study/NCT03652753","title":"Prevention of Cartilage Cell Death Following a Pilon Fracture With Intra-articular Injection of N-Acetylcysteine (Pilon NAC)","has_exemption":false,"start_date":"2019-01-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03899402","publication_url":"https://clinicaltrials.gov/study/NCT03899402","title":"Triple Therapy for Type 1 Diabetes With Insulin, Semaglutide, and Dapagliflozin","has_exemption":false,"start_date":"2019-05-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"State University of New York at Buffalo","sponsor_slug":"state-university-of-new-york-at-buffalo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03799874","publication_url":"https://clinicaltrials.gov/study/NCT03799874","title":"A Phase II Trial of Inhaled Carbon Monoxide for the Treatment of Acute Respiratory Distress Syndrome (ARDS)","has_exemption":false,"start_date":"2019-07-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03977662","publication_url":"https://clinicaltrials.gov/study/NCT03977662","title":"Pancreatic Islets and Parathyroid Gland Co-transplantation for Treatment of Diabetes in the Intra-Muscular Site","has_exemption":false,"start_date":"2019-07-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Peter Stock","sponsor_slug":"peter-stock","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03786692","publication_url":"https://clinicaltrials.gov/study/NCT03786692","title":"TH-138: Phase II Randomized Trial of Carboplatin + Pemetrexed + Bevacizumab, With or Without Atezolizumab in Stage IV Non-squamous NSCLC Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked","has_exemption":false,"start_date":"2019-09-04","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04036682","publication_url":"https://clinicaltrials.gov/study/NCT04036682","title":"A Phase 1/2, Open-Label, Multi-Center Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of CLN-081 in Patients With Locally-Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Previously Received Platinum-Based Systemic Chemotherapy","has_exemption":false,"start_date":"2019-10-31","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Cullinan Therapeutics Inc.","sponsor_slug":"cullinan-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04152551","publication_url":"https://clinicaltrials.gov/study/NCT04152551","title":"Effects of Bisphosphonates on OI-Related Hearing Loss: A Pilot Study","has_exemption":false,"start_date":"2019-11-02","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05215132","publication_url":"https://clinicaltrials.gov/study/NCT05215132","title":"Study Evaluation of Feasibility and Reproducibility of Investigational MRI Clinical Software","has_exemption":false,"start_date":"2019-12-19","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04221503","publication_url":"https://clinicaltrials.gov/study/NCT04221503","title":"A Phase II Study Evaluating the Efficacy and Safety of Niraparib and Tumor-Treating Fields in Recurrent Glioblastoma","has_exemption":false,"start_date":"2019-12-30","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04009044","publication_url":"https://clinicaltrials.gov/study/NCT04009044","title":"A Phase II Study of the Determinants of Transdermal Drug Delivery to the Normal and the Radiated Breast","has_exemption":false,"start_date":"2020-02-17","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04130854","publication_url":"https://clinicaltrials.gov/study/NCT04130854","title":"INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer, a Phase II Randomized Multi-center Trial With and Without APX005M, an Anti-CD40 Agonist","has_exemption":false,"start_date":"2020-04-24","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04519749","publication_url":"https://clinicaltrials.gov/study/NCT04519749","title":"An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease","has_exemption":false,"start_date":"2020-09-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"4D Molecular Therapeutics","sponsor_slug":"4d-molecular-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04494347","publication_url":"https://clinicaltrials.gov/study/NCT04494347","title":"Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR)","has_exemption":false,"start_date":"2020-11-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04375813","publication_url":"https://clinicaltrials.gov/study/NCT04375813","title":"Phase II Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention","has_exemption":false,"start_date":"2021-01-25","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Robert Svatek","sponsor_slug":"robert-svatek","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04419779","publication_url":"https://clinicaltrials.gov/study/NCT04419779","title":"A Prospective, Randomized, Double-Blind, Sham-Controlled, Multi-Center, Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita® System in Subjects With Type 2 Diabetes With Inadequate Glycemic Control","has_exemption":false,"start_date":"2021-03-08","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Fractyl Health, Inc.","sponsor_slug":"fractyl-health-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04814615","publication_url":"https://clinicaltrials.gov/study/NCT04814615","title":"A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma: Phase 2 Trial of Clinical Applications","has_exemption":false,"start_date":"2021-03-08","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Hoag Memorial Hospital Presbyterian","sponsor_slug":"hoag-memorial-hospital-presbyterian","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04077346","publication_url":"https://clinicaltrials.gov/study/NCT04077346","title":"Neuromodulation of Spinal Locomotor Circuitry to Elicit Stepping After Pediatric Spinal Cord Injury","has_exemption":false,"start_date":"2021-04-12","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04730258","publication_url":"https://clinicaltrials.gov/study/NCT04730258","title":"Phase 1b/2 Clinical Study of the Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Profiles of CFI-400945 as a Single Agent or in Combination With Azacitidine in Patients With AML, MDS or CMML","has_exemption":false,"start_date":"2021-04-16","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Treadwell Therapeutics, Inc","sponsor_slug":"treadwell-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04610294","publication_url":"https://clinicaltrials.gov/study/NCT04610294","title":"Operating Room Air Filtration/Sterilization and Surgical Site Infection: A Randomized Multiple Cross-over Cluster Trial","has_exemption":false,"start_date":"2021-05-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04838288","publication_url":"https://clinicaltrials.gov/study/NCT04838288","title":"Cognitive Outcomes and Quality of Life in Stable Renal Transplant Patients Switched FromTwice-Daily Tacrolimus to Envarsus XR™","has_exemption":false,"start_date":"2021-06-22","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05114421","publication_url":"https://clinicaltrials.gov/study/NCT05114421","title":"Immunomodulation of the Tumor Microenvironment in High-Grade Serous Ovarian Cancer Patients Receiving Pembrolizumab and Lenvatinib Monotherapy and Combination Therapy","has_exemption":false,"start_date":"2021-11-09","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05191706","publication_url":"https://clinicaltrials.gov/study/NCT05191706","title":"A Phase 3/4, Prospective, Randomized, Active Treatment-Controlled, Parallel-Design, Multicenter Study to Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract","has_exemption":false,"start_date":"2022-01-04","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"EyePoint Pharmaceuticals, Inc.","sponsor_slug":"eyepoint-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05156268","publication_url":"https://clinicaltrials.gov/study/NCT05156268","title":"A Phase II Trial of Pembrolizumab Plus Olaparib for the Treatment of Patients With Persistent/Recurrent Endometrial Cancers","has_exemption":false,"start_date":"2022-01-27","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05241249","publication_url":"https://clinicaltrials.gov/study/NCT05241249","title":"Phase II, Neoadjuvant Study of Parasympathetic Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Borderline Resectable Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2022-02-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Susan E. Bates","sponsor_slug":"susan-e-bates","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05746143","publication_url":"https://clinicaltrials.gov/study/NCT05746143","title":"The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion: A Randomized Control Trial","has_exemption":false,"start_date":"2022-02-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05177536","publication_url":"https://clinicaltrials.gov/study/NCT05177536","title":"Phase 2 Study of Iberdomide Maintenance Therapy Following Autologous Stem Cell Transplant in Patients With Multiple Myeloma","has_exemption":false,"start_date":"2022-04-15","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05357482","publication_url":"https://clinicaltrials.gov/study/NCT05357482","title":"Addition of JSP191 (C-kit Antibody) to Non-myeloablative Hematopoietic Cell Transplantation For Sickle Cell Disease and Beta-Thalassemia","has_exemption":false,"start_date":"2022-05-12","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","sponsor_slug":"national-heart-lung-and-blood-institute-nhlbi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04700488","publication_url":"https://clinicaltrials.gov/study/NCT04700488","title":"MRI Imaging to Predict Outcomes of Treatment in PDAC Patients","has_exemption":false,"start_date":"2022-05-19","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04634357","publication_url":"https://clinicaltrials.gov/study/NCT04634357","title":"An Open-Label, Dose Escalation, Phase I/II Clinical Trial of ET140203 T Cells in Pediatric Subjects With Relapsed/Refractory Hepatoblastoma (HB), Hepatocellular Neoplasm-Not Otherwise Specified (HCN-NOS), or Hepatocellular Carcinoma (HCC)","has_exemption":false,"start_date":"2022-07-19","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Eureka Therapeutics Inc.","sponsor_slug":"eureka-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05297448","publication_url":"https://clinicaltrials.gov/study/NCT05297448","title":"A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis","has_exemption":false,"start_date":"2022-08-03","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Bausch Health Americas, Inc.","sponsor_slug":"bausch-health-americas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05206422","publication_url":"https://clinicaltrials.gov/study/NCT05206422","title":"DORAYA-HF: Assessment of the Doraya Catheter for the Treatment of Volume Overload in Acute Heart Failure Patients With Insufficient Response to Diuretics","has_exemption":false,"start_date":"2022-10-05","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Revamp Medical Inc.","sponsor_slug":"revamp-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05565417","publication_url":"https://clinicaltrials.gov/study/NCT05565417","title":"A Phase 1/2a, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas","has_exemption":false,"start_date":"2022-11-28","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Immunitas Therapeutics","sponsor_slug":"immunitas-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05364502","publication_url":"https://clinicaltrials.gov/study/NCT05364502","title":"A Prospective Multicenter Single-Arm Staged Study to Evaluate the Safety and Effectiveness of Embrace™ Hydrogel Embolic For Transcatheter Embolization of Arterial Bleeding in Solid Organs and Peripheral Arteries","has_exemption":false,"start_date":"2022-12-12","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Instylla, Inc.","sponsor_slug":"instylla-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05581199","publication_url":"https://clinicaltrials.gov/study/NCT05581199","title":"A Phase 2b, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study of Batoclimab Treatment in Adult Participants With Active Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","has_exemption":false,"start_date":"2022-12-15","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Immunovant Sciences GmbH","sponsor_slug":"immunovant-sciences-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05599048","publication_url":"https://clinicaltrials.gov/study/NCT05599048","title":"A Phase I/II Study of Hyperpolarized 13C MRI as a Biomarker of Aggressiveness & Response to Therapy in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2022-12-15","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Robert Bok, MD, PhD","sponsor_slug":"robert-bok-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05583344","publication_url":"https://clinicaltrials.gov/study/NCT05583344","title":"17 β-Hydroxysteroid Dehydrogenase Type 13 Minimization for the Treatment of NASH (HORIZON): A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of GSK4532990 in Adults With Nonalcoholic Steatohepatitis","has_exemption":false,"start_date":"2023-01-02","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05649904","publication_url":"https://clinicaltrials.gov/study/NCT05649904","title":"Use of Active Fluid Exchange to Therapeutically Treat Intracranial Bleeding and Infection","has_exemption":false,"start_date":"2023-02-07","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05703425","publication_url":"https://clinicaltrials.gov/study/NCT05703425","title":"The Effect of Sulfasalazine on CRH Levels in Pregnant Women With a History of Pre-Term Birth: A Randomized Controlled Trial","has_exemption":false,"start_date":"2023-03-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05705505","publication_url":"https://clinicaltrials.gov/study/NCT05705505","title":"A Multi-center Phase 1/2a Study of Narazaciclib (ON 123300) in Combination With Letrozole as Therapy for the Treatment of Recurrent Metastatic Endometrial Cancer and Other Gynecologic Malignancies","has_exemption":false,"start_date":"2023-03-29","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Traws Pharma, Inc.","sponsor_slug":"traws-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05560477","publication_url":"https://clinicaltrials.gov/study/NCT05560477","title":"A Prospective, Randomized, Controlled, Double-Blinded, Multi-Center, Phase 1/2b Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing","has_exemption":false,"start_date":"2023-04-26","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05499741","publication_url":"https://clinicaltrials.gov/study/NCT05499741","title":"Piloting Forehead Temperature-Regulating Therapy for Insomnia in Adults With Tourette's Disorder","has_exemption":false,"start_date":"2023-04-27","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05855135","publication_url":"https://clinicaltrials.gov/study/NCT05855135","title":"Assessment of the Safety and Efficacy of a Combined Cardiac Contractility Modulation and Implantable Cardioverter Defibrillator Device for Subjects With Heart Failure and Reduced Ejection Fraction","has_exemption":false,"start_date":"2023-05-17","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Impulse Dynamics","sponsor_slug":"impulse-dynamics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05596409","publication_url":"https://clinicaltrials.gov/study/NCT05596409","title":"ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer: An Open-Label Multicenter Phase 2 Study (ELCIN)","has_exemption":false,"start_date":"2023-05-19","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Stemline Therapeutics, Inc.","sponsor_slug":"stemline-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05887492","publication_url":"https://clinicaltrials.gov/study/NCT05887492","title":"A Phase 1/2, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of TNG260 as Single Agent and in Combination With an Anti-PD-1 Antibody In Patients With STK11 Mutated Advanced Solid Tumors","has_exemption":false,"start_date":"2023-06-12","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Tango Therapeutics, Inc.","sponsor_slug":"tango-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05825417","publication_url":"https://clinicaltrials.gov/study/NCT05825417","title":"A Multicentre Randomised Cross-over Trial of Disease Specific Therapy in Patients With Pulmonary Arterial Hypertension (PAH) Implanted With Pulmonary Artery Pressure and Cardiac Rhythm Monitoring Devices (CardioMEMS/ConfirmRx)","has_exemption":false,"start_date":"2023-06-14","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Sheffield Teaching Hospitals NHS Foundation Trust","sponsor_slug":"sheffield-teaching-hospitals-nhs-foundation-trust","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05696717","publication_url":"https://clinicaltrials.gov/study/NCT05696717","title":"A Phase 3, Multi-center, Randomized Withdrawal and Long Term Extension Study of Ampreloxetine for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Participants With Multiple System Atrophy","has_exemption":false,"start_date":"2023-06-27","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Theravance Biopharma","sponsor_slug":"theravance-biopharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05750654","publication_url":"https://clinicaltrials.gov/study/NCT05750654","title":"Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia: A Randomized Controlled Trial","has_exemption":false,"start_date":"2023-07-24","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05838430","publication_url":"https://clinicaltrials.gov/study/NCT05838430","title":"The Effects of Solriamfetol and CBT-I (Alone and in Combination) on Sleep Continuity, Sleepiness, Fatigue, and Performance in Patients With Insomnia Disorder","has_exemption":false,"start_date":"2023-07-31","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05887635","publication_url":"https://clinicaltrials.gov/study/NCT05887635","title":"A Pilot Human Investigation of the Safety, Tolerability and Effectiveness of the Aqua Medical Circumferential RF Vapor (RFV) Ablation System for Duodenal Mucosal Ablation for the Management of Type-2 Diabetes Mellitus (STEAM T-2DM Pilot)","has_exemption":false,"start_date":"2023-09-02","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Aqua Medical, Inc.","sponsor_slug":"aqua-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05984927","publication_url":"https://clinicaltrials.gov/study/NCT05984927","title":"A Phase 1/2a Open-label Study to Evaluate Safety, Tolerability and Preliminary Efficacy of NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration","has_exemption":false,"start_date":"2023-09-08","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Elisigen, Inc.","sponsor_slug":"elisigen-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05615649","publication_url":"https://clinicaltrials.gov/study/NCT05615649","title":"Expanded Indications in the Pediatric BONEBRIDGE Population","has_exemption":false,"start_date":"2023-10-03","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Med-El Corporation","sponsor_slug":"med-el-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05701098","publication_url":"https://clinicaltrials.gov/study/NCT05701098","title":"Pivotal Study of the SonoMotion Break Wave™ (Trade Mark) System for the Comminution of Urinary Tract Stones","has_exemption":false,"start_date":"2023-10-09","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"SonoMotion","sponsor_slug":"sonomotion","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06054880","publication_url":"https://clinicaltrials.gov/study/NCT06054880","title":"An Open-Label, Randomized, Multicenter Study to Evaluate the Safety, Efficacy, and Physician Satisfaction of Two Different Doses of Bludigo™ When Used as an Aid in the Determination of Ureteral Patency","has_exemption":false,"start_date":"2023-10-12","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Prove pharm","sponsor_slug":"prove-pharm","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05883631","publication_url":"https://clinicaltrials.gov/study/NCT05883631","title":"Prospective, Single Arm, Multi-center, Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-pulmonary Vein Sources of Atrial Fibrillation and Guide Ablation Therapy.","has_exemption":false,"start_date":"2023-10-23","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Cortex","sponsor_slug":"cortex","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05947383","publication_url":"https://clinicaltrials.gov/study/NCT05947383","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of up to Two Doses of Psilocybin for the Treatment of Major Depressive Disorder in Adults With Cancer","has_exemption":false,"start_date":"2023-10-23","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Sunstone Medical","sponsor_slug":"sunstone-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06046820","publication_url":"https://clinicaltrials.gov/study/NCT06046820","title":"The ENERGY 3 Study: A Randomized, Controlled, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of INZ-701 in Children With Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Deficiency","has_exemption":false,"start_date":"2023-11-05","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Inozyme Pharma","sponsor_slug":"inozyme-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06146842","publication_url":"https://clinicaltrials.gov/study/NCT06146842","title":"A Trial to Determine the Optimal Bupivacaine Dose for Initiation of Labor Epidural Pain Relief with a Lidocaine Test Dose","has_exemption":false,"start_date":"2023-12-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06127043","publication_url":"https://clinicaltrials.gov/study/NCT06127043","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis","has_exemption":false,"start_date":"2023-12-04","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"AnaptysBio, Inc.","sponsor_slug":"anaptysbio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03630081","publication_url":"https://clinicaltrials.gov/study/NCT03630081","title":"A Phase III, Randomized, Double-Blind, Multicenter, Comparative Study to Determine the Efficacy and Safety of Cefepime-Tazobactam vs. Meropenem Followed by Optional Oral Therapy in the Treatment of Complicated Urinary Tract Infection or Acute Pyelonephritis in Adults","has_exemption":false,"start_date":"2024-01-31","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Wockhardt","sponsor_slug":"wockhardt","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06015724","publication_url":"https://clinicaltrials.gov/study/NCT06015724","title":"A Phase 2 Study Evaluating the Efficacy of Anti-CD38 Antibody in Combination With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2024-01-31","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Georgetown University","sponsor_slug":"georgetown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06204159","publication_url":"https://clinicaltrials.gov/study/NCT06204159","title":"Lipiodol Deposition in Hypervascular Tumors: Endhole vs. Pressure-modulated Delivery","has_exemption":false,"start_date":"2024-02-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06196203","publication_url":"https://clinicaltrials.gov/study/NCT06196203","title":"A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2 Study of AK117/Placebo in Combination With Azacitidine in Patients With Newly Diagnosed Higher-risk Myelodysplastic Syndromes","has_exemption":false,"start_date":"2024-02-07","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Akeso","sponsor_slug":"akeso","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07246512","publication_url":"https://clinicaltrials.gov/study/NCT07246512","title":"Comparison Between MTA and TotalFill® BC-RRM Fast Set Putty for Retrograde Filling in Apical Surgery: Randomized Non-inferiority Clinical Trial.","has_exemption":false,"start_date":"2024-02-08","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Valencia","sponsor_slug":"university-of-valencia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05986864","publication_url":"https://clinicaltrials.gov/study/NCT05986864","title":"Phase I/II Study to Evaluate the Safety and Preliminary Efficacy of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)","has_exemption":false,"start_date":"2024-02-23","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Skyline Therapeutics (US) Inc.","sponsor_slug":"skyline-therapeutics-us-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06209736","publication_url":"https://clinicaltrials.gov/study/NCT06209736","title":"A Phase 2 Proof of Concept Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of OMS906 in Patients With C3 Glomerulopathy (C3G) and Idiopathic Immune Complex-Mediated Glomerulonephritis (ICGN)","has_exemption":false,"start_date":"2024-03-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Omeros Corporation","sponsor_slug":"omeros-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06048133","publication_url":"https://clinicaltrials.gov/study/NCT06048133","title":"Study of Gemcitabine, Cisplatin, Quemliclustat (AB680) and Zimberelimab (AB122) During First-line Treatment of Advanced Biliary Tract Cancers (QUIC)","has_exemption":false,"start_date":"2024-03-08","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Nataliya Uboha","sponsor_slug":"nataliya-uboha","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06063122","publication_url":"https://clinicaltrials.gov/study/NCT06063122","title":"Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants","has_exemption":false,"start_date":"2024-03-08","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Thrive Neuromedical, LLC","sponsor_slug":"thrive-neuromedical-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05835206","publication_url":"https://clinicaltrials.gov/study/NCT05835206","title":"A Randomized Controlled Trial to Further Microbiota Therapy for Antibiotic-Resistant Bacterial Colonization in Inpatients.","has_exemption":false,"start_date":"2024-04-25","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06270836","publication_url":"https://clinicaltrials.gov/study/NCT06270836","title":"A Prospective, Randomized, Double-masked, Sham-controlled, Multi-center, Two-arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal Tarcocimab Tedromer in Participants With Diabetic Retinopathy (DR) - GLOW2","has_exemption":false,"start_date":"2024-05-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Kodiak Sciences Inc","sponsor_slug":"kodiak-sciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04889742","publication_url":"https://clinicaltrials.gov/study/NCT04889742","title":"Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors","has_exemption":false,"start_date":"2024-05-10","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Charite University, Berlin, Germany","sponsor_slug":"charite-university-berlin-germany","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06728969","publication_url":"https://clinicaltrials.gov/study/NCT06728969","title":"A Prospective Comparative Study to Evaluate a Novel Algorithm Using Data Derived from a Non-Invasive Digital Biomarker As a Diagnostic Aid for ADHD in Youth Ages 6-17.","has_exemption":false,"start_date":"2024-06-02","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"MindTension","sponsor_slug":"mindtension","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06252532","publication_url":"https://clinicaltrials.gov/study/NCT06252532","title":"Modulating Oscillations and Working Memory in Patients With Subdural Electrodes","has_exemption":false,"start_date":"2024-07-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06500468","publication_url":"https://clinicaltrials.gov/study/NCT06500468","title":"Usage of Novel Blood Sensing Capsule in Emergency Department to Triage Patients With Suspected Upper Gastrointestinal Bleeding","has_exemption":false,"start_date":"2024-07-18","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Tan Tock Seng Hospital","sponsor_slug":"tan-tock-seng-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06500416","publication_url":"https://clinicaltrials.gov/study/NCT06500416","title":"Visual Outcomes Following Implantation of Tecnis Symfony Opti-Blue EDOF IOL in Patients With Mild to Moderate Retinal Ocular Comorbidities","has_exemption":false,"start_date":"2024-08-31","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Coastal Eye Surgeons PLLC","sponsor_slug":"coastal-eye-surgeons-pllc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06558279","publication_url":"https://clinicaltrials.gov/study/NCT06558279","title":"A Randomized, Double-Blinded, Placebo-Controlled, Phase 3, Parallel-Group Design Study Evaluating the Efficacy and Safety of Efgartigimod PH20 SC Administered by Prefilled Syringe in Adult Participants With Ocular Myasthenia Gravis","has_exemption":false,"start_date":"2024-09-18","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06558799","publication_url":"https://clinicaltrials.gov/study/NCT06558799","title":"LUNAR-4: Pilot, Single Arm, Open-Label, Multinational Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC) Previously Treated With a PD-1/PD-L1 Inhibitor and Platinum-Based Chemotherapy","has_exemption":false,"start_date":"2024-10-14","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"NovoCure GmbH","sponsor_slug":"novocure-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06328751","publication_url":"https://clinicaltrials.gov/study/NCT06328751","title":"Study With Cancer Patients at the CECON Foundation's Pain Therapy and Palliative Care Service: Meditation With Immersive Virtual Reality for Pain Relief","has_exemption":false,"start_date":"2024-11-07","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Emily Santos Montarroyos","sponsor_slug":"emily-santos-montarroyos","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06226610","publication_url":"https://clinicaltrials.gov/study/NCT06226610","title":"A Phase 2 Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy of Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic","has_exemption":false,"start_date":"2024-11-21","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Akron Children's Hospital","sponsor_slug":"akron-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06595030","publication_url":"https://clinicaltrials.gov/study/NCT06595030","title":"Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 3","has_exemption":false,"start_date":"2024-12-03","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06777433","publication_url":"https://clinicaltrials.gov/study/NCT06777433","title":"An Open-Label, Single Dose, Single Arm, Multicenter Phase 2b Study to Establish the Imaging Performance of RAD101 Positron Emission Tomography (PET) in Participants With Suspected Recurrent Brain Metastases From Solid Tumors","has_exemption":false,"start_date":"2024-12-13","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Radiopharm Theranostics, Ltd","sponsor_slug":"radiopharm-theranostics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06737068","publication_url":"https://clinicaltrials.gov/study/NCT06737068","title":"Low Pressure Pneumoperitoneum Using AirSeal® for Reduction in Postoperative Shoulder Pain Following Robot Assisted Hiatal Hernia Repair: a Prospective Randomized Controlled Trial.","has_exemption":false,"start_date":"2025-01-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Riverside University Health System Medical Center","sponsor_slug":"riverside-university-health-system-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06757335","publication_url":"https://clinicaltrials.gov/study/NCT06757335","title":"A Multicenter, Open, Dose Escalation/dose Escalation, and Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Oral HP568 Tablets Alone and in Combination with Palbociclib in Patients with ER+/HER2 Advanced Breast Cancer","has_exemption":false,"start_date":"2025-01-07","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Hinova Pharmaceuticals Inc.","sponsor_slug":"hinova-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06805838","publication_url":"https://clinicaltrials.gov/study/NCT06805838","title":"Prolonged Manual Ventilation Simulation","has_exemption":false,"start_date":"2025-01-25","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"SafeBVM","sponsor_slug":"safebvm","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06805513","publication_url":"https://clinicaltrials.gov/study/NCT06805513","title":"Actual Use Trial to Switch Tadalafil 5 mg Tablets From Prescription to Over-the-Counter","has_exemption":false,"start_date":"2025-01-30","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06548386","publication_url":"https://clinicaltrials.gov/study/NCT06548386","title":"Feasibility and Accuracy of a Novel Pleural Drain Gas Analyzer in Detecting Air Leaks","has_exemption":false,"start_date":"2025-02-05","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Lung Healing Technologies Inc","sponsor_slug":"lung-healing-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06855459","publication_url":"https://clinicaltrials.gov/study/NCT06855459","title":"A Randomized Double Blinded and Placebo-Controlled Trial to Assess the Impact of Biophoton Therapy on Self-Grown Stem Cells","has_exemption":false,"start_date":"2025-02-10","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"First Institute of All Medicines","sponsor_slug":"first-institute-of-all-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06362928","publication_url":"https://clinicaltrials.gov/study/NCT06362928","title":"Safety and Effectiveness of the Akura Thrombectomy System in the Treatment of Acute Pulmonary Embolism","has_exemption":false,"start_date":"2025-02-15","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Akura Medical","sponsor_slug":"akura-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06820164","publication_url":"https://clinicaltrials.gov/study/NCT06820164","title":"Lipomas Treated with Subcutaneous Injections of Cooled Sodium Chloride: an Exploratory Study","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"West Virginia University","sponsor_slug":"west-virginia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06828601","publication_url":"https://clinicaltrials.gov/study/NCT06828601","title":"Perioperative Lidocaine Infusions for the Management of Pain From Burn Injury: A Pilot Study to Investigate Analgesic and Opioid Sparing Effects","has_exemption":false,"start_date":"2025-04-30","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06487585","publication_url":"https://clinicaltrials.gov/study/NCT06487585","title":"Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery (ANG-First Trial)","has_exemption":false,"start_date":"2025-05-06","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland St. Joseph Medical Center","sponsor_slug":"university-of-maryland-st-joseph-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07089615","publication_url":"https://clinicaltrials.gov/study/NCT07089615","title":"Prospective, Open Label, Pivotal Study of the Accuracy of the CapsoCam® Colon (CV-3) in Detecting Colonic Polyps, Using Colonoscopy as the Reference","has_exemption":false,"start_date":"2025-06-26","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Capso Vision, Inc.","sponsor_slug":"capso-vision-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06714864","publication_url":"https://clinicaltrials.gov/study/NCT06714864","title":"An Open-Label, Two-Arm (DefenCath® vs. Institutional Standard of Care) Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to Less Than 18 Years of Age With Kidney Failure Receiving Hemodialysis Via a Central Venous Catheter","has_exemption":false,"start_date":"2025-07-08","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"CorMedix","sponsor_slug":"cormedix","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07090928","publication_url":"https://clinicaltrials.gov/study/NCT07090928","title":"Effectiveness of Per-Operative Bupivicaine in Reducing Postoperative Pain at Port Site and Improving Mobility in Knee Arthoscopic Procedures","has_exemption":false,"start_date":"2025-08-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Khyber Teaching Hospital","sponsor_slug":"khyber-teaching-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05966896","publication_url":"https://clinicaltrials.gov/study/NCT05966896","title":"Epidural Stimulation to Restore Voluntary Movement Following Spinal Cord Injury: Spared Fibers Proof-of-concept Study","has_exemption":false,"start_date":"2025-08-31","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07078669","publication_url":"https://clinicaltrials.gov/study/NCT07078669","title":"Comparison of Patient Outcomes With Dyed vs. Undyed Polyglactin Sutures in Cutaneous Surgery","has_exemption":false,"start_date":"2025-08-31","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"West Virginia University","sponsor_slug":"west-virginia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06967428","publication_url":"https://clinicaltrials.gov/study/NCT06967428","title":"Effectiveness of Metabolic Modulation in Treating Post-vaccination Syndrome: A Prospective Study","has_exemption":false,"start_date":"2025-09-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Independent Medical Alliance","sponsor_slug":"independent-medical-alliance","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07168564","publication_url":"https://clinicaltrials.gov/study/NCT07168564","title":"Post Market Clinical Study to Compare Vision With Essilor® AVA™ Lenses Following AVA™ Refraction Protocol to Equivalent Lenses Following Gold Standard Refraction Protocol.","has_exemption":false,"start_date":"2025-09-22","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Essilor International","sponsor_slug":"essilor-international","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220174","publication_url":"https://clinicaltrials.gov/study/NCT07220174","title":"Pilot Usability Evaluation of GI Genius™ XR Software Running on a Virtual Reality Headset During Routine CRC Screening and Surveillance Colonoscopies","has_exemption":false,"start_date":"2025-10-31","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Cosmo Artificial Intelligence-AI Ltd","sponsor_slug":"cosmo-artificial-intelligence-ai-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07266948","publication_url":"https://clinicaltrials.gov/study/NCT07266948","title":"Evaluating the Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work","has_exemption":false,"start_date":"2025-11-01","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"Southern College of Optometry","sponsor_slug":"southern-college-of-optometry","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07228416","publication_url":"https://clinicaltrials.gov/study/NCT07228416","title":"Milky Way Sensor: Device Validation for Non-Infiltrated Tissues","has_exemption":false,"start_date":"2025-12-31","completion_date":"2026-01-31","has_results":false,"results_due":false,"sponsor_name":"ivWatch, LLC","sponsor_slug":"ivwatch-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03564340","publication_url":"https://clinicaltrials.gov/study/NCT03564340","title":"A Phase 1/2 Study of REGN4018 (Ubamatamab), a MUC16×CD3 Bispecific Antibody, Administered Alone or in Combination With Cemiplimab in Patients With Recurrent Ovarian Cancer or Other Recurrent MUC16+ Cancers","has_exemption":false,"start_date":"2018-05-21","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04054310","publication_url":"https://clinicaltrials.gov/study/NCT04054310","title":"Non-Invasive Quantification of Liver Health in NASH (N-QUAN): A Prospective Diagnostic Accuracy Study","has_exemption":false,"start_date":"2020-08-05","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"Perspectum","sponsor_slug":"perspectum","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04421248","publication_url":"https://clinicaltrials.gov/study/NCT04421248","title":"Anomalous Motor System Physiology in Attention Deficit Hyperactivity Disorder: Biomarker Validation and Modeling Domains of Function","has_exemption":false,"start_date":"2020-09-01","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"Donald Gilbert, MD, MS, FAAN, FAAP","sponsor_slug":"donald-gilbert-md-ms-faan-faap","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05232253","publication_url":"https://clinicaltrials.gov/study/NCT05232253","title":"Measurement of Bladder Pressure With a Novel External Device (Cystoealstometer) - Home","has_exemption":false,"start_date":"2021-01-18","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05150197","publication_url":"https://clinicaltrials.gov/study/NCT05150197","title":"Virtual Reality Visual Field Testing as an Alternative to Standard Automated Perimetry in Childhood Eye Disease","has_exemption":false,"start_date":"2022-01-19","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04968405","publication_url":"https://clinicaltrials.gov/study/NCT04968405","title":"Analysis of the Performance and Safety of the Catalyst CSR Shoulder System - A Prospective Study","has_exemption":false,"start_date":"2022-07-22","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"Catalyst OrthoScience","sponsor_slug":"catalyst-orthoscience","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05762302","publication_url":"https://clinicaltrials.gov/study/NCT05762302","title":"A Multicenter Randomized Controlled Trial to Establish the Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) (\"JUPITER\" TRIAL)","has_exemption":false,"start_date":"2023-01-31","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"MeMed Diagnostics Ltd.","sponsor_slug":"memed-diagnostics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05858619","publication_url":"https://clinicaltrials.gov/study/NCT05858619","title":"Molecular Signatures of Cutaneous Dupilumab Response","has_exemption":false,"start_date":"2023-02-01","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05800600","publication_url":"https://clinicaltrials.gov/study/NCT05800600","title":"Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy","has_exemption":false,"start_date":"2023-03-15","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05501665","publication_url":"https://clinicaltrials.gov/study/NCT05501665","title":"SiCARIO (Split Course Adaptive Radioimmunotherapy) for the Treatment of Oligometastatic Non-Small Cell Lung Cancer (NSCLC) Using Biologically-Adaptive Radiotherapy - A Phase I/II Study","has_exemption":false,"start_date":"2023-05-09","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt-Ingram Cancer Center","sponsor_slug":"vanderbilt-ingram-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05600686","publication_url":"https://clinicaltrials.gov/study/NCT05600686","title":"A Phase 2 Study of Loncastuximab Tesirine and Rituximab (Lonca-R) Followed by DA-EPOCH-R in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma","has_exemption":false,"start_date":"2023-05-24","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"Joseph Tuscano","sponsor_slug":"joseph-tuscano","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05802186","publication_url":"https://clinicaltrials.gov/study/NCT05802186","title":"A Single-Arm Phase II Study of Personalized Dose Guidance for Stereotactic Body Radiotherapy (SBRT) in Patients With Lung Tumors","has_exemption":false,"start_date":"2023-11-20","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06205043","publication_url":"https://clinicaltrials.gov/study/NCT06205043","title":"Enhancing Deep Brain Stimulation Programming for Parkinson's Disease: A Semi- Automatic Algorithm-Guided Approach Using StimSearch- A Double Blind Randomized Study","has_exemption":false,"start_date":"2024-01-10","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"Jaslok Hospital and Research Centre","sponsor_slug":"jaslok-hospital-and-research-centre","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05913284","publication_url":"https://clinicaltrials.gov/study/NCT05913284","title":"Intravenous Methadone in Perioperative Acute and Chronic Management in Chinese Adult Cardiac Surgical Patients: a Pilot Randomized Controlled Trial","has_exemption":false,"start_date":"2024-01-15","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"Chinese University of Hong Kong","sponsor_slug":"chinese-university-of-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06375928","publication_url":"https://clinicaltrials.gov/study/NCT06375928","title":"Endoscopic Ultrasound-Guided Biliary Drainage With Lumen-Apposing Stent vs Classical ERCP for First-line Therapy of Malignant Distal Biliary Obstruction in Resectable Disease: An Open-label, Multicenter Randomized Controlled Trial (CARPEDIEM-1 Trial)","has_exemption":false,"start_date":"2024-05-01","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"Hospital Universitari de Bellvitge","sponsor_slug":"hospital-universitari-de-bellvitge","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06109285","publication_url":"https://clinicaltrials.gov/study/NCT06109285","title":"Validation of i-ROP DL to Detect More Than Mild Retinopathy of Prematurity and a Multi-Reader Multi-Case Controlled Clinical Trial to Evaluate the Comparative Accuracy of Diagnosing Plus Disease of Premature Infants With or Without the Aid of the i-ROP DL in Telemedicine Setting","has_exemption":false,"start_date":"2024-06-25","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"Siloam Vision","sponsor_slug":"siloam-vision","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06257537","publication_url":"https://clinicaltrials.gov/study/NCT06257537","title":"Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"ZetrOZ, Inc.","sponsor_slug":"zetroz-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06574646","publication_url":"https://clinicaltrials.gov/study/NCT06574646","title":"Visual Acuity Outcome Differences Between the Alcon Vivity Toric IOL and RxSight LAL+","has_exemption":false,"start_date":"2024-10-15","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"The Eye Associates","sponsor_slug":"the-eye-associates","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06760702","publication_url":"https://clinicaltrials.gov/study/NCT06760702","title":"A Phase II, Open-label, Randomized, Dose-ranging Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal Cancers (TEJAS-2)","has_exemption":false,"start_date":"2024-11-09","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"Aurigene Discovery Technologies Limited","sponsor_slug":"aurigene-discovery-technologies-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06308926","publication_url":"https://clinicaltrials.gov/study/NCT06308926","title":"A Phase IIa, Double-Blind, Randomized, Multi-Center Study Comparing MRG-001 to Placebo in Patients With Acute Respiratory Distress Syndrome","has_exemption":false,"start_date":"2024-12-01","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"MedRegen LLC","sponsor_slug":"medregen-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06628219","publication_url":"https://clinicaltrials.gov/study/NCT06628219","title":"A Global, Prospective, Real-World, Investigation of the Symani® Surgical System for Microsurgical Anastomosis: Expanding Access to Care in Free Tissue Transfer Surgery and Lymphatic Surgery","has_exemption":false,"start_date":"2025-02-01","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"MMI (Medical Microinstruments, Inc.)","sponsor_slug":"mmi-medical-microinstruments-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06843538","publication_url":"https://clinicaltrials.gov/study/NCT06843538","title":"Peri-operative Tamsulosin and Impact on Voiding Trial Following Outpatient Urogynecology Surgery: a Randomized Controlled Trial","has_exemption":false,"start_date":"2025-02-03","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"TriHealth Inc.","sponsor_slug":"trihealth-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06608901","publication_url":"https://clinicaltrials.gov/study/NCT06608901","title":"A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamic Effects of REGN7544, an Antagonist Monoclonal Antibody to NPR1, in Patients With Sepsis-Induced Hypotension","has_exemption":false,"start_date":"2025-05-05","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07111390","publication_url":"https://clinicaltrials.gov/study/NCT07111390","title":"A Feasibility Pilot Study of Home-Based Intermittent 60Hz Light Therapy for the Treatment of Depression","has_exemption":false,"start_date":"2025-08-18","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06974084","publication_url":"https://clinicaltrials.gov/study/NCT06974084","title":"A Multi-Center Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVID/Post-Acute Sequalae of Covid (PASC)","has_exemption":false,"start_date":"2025-09-01","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"HealthBio, Inc.","sponsor_slug":"healthbio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07144904","publication_url":"https://clinicaltrials.gov/study/NCT07144904","title":"A Side-Randomized, Self-Controlled Trial Assessing the Efficacy of Indocyanine Green Fluorescence Imaging for Intraoperative Ureter Identification During Robot-Assisted Single-Site Surgery in Advanced-Stage Endometriosis","has_exemption":false,"start_date":"2025-10-01","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07452276","publication_url":"https://clinicaltrials.gov/study/NCT07452276","title":"Effect of Artificial Intelligence-Based Training on Cognitive Functions in Patients With Stroke","has_exemption":false,"start_date":"2026-01-01","completion_date":"2026-02-01","has_results":false,"results_due":false,"sponsor_name":"Omima Alaa Eldin Hussein","sponsor_slug":"omima-alaa-eldin-hussein","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03749018","publication_url":"https://clinicaltrials.gov/study/NCT03749018","title":"A Phase II Study of Nivolumab in Combination With DA-REPOCH Followed by Short Course Nivolumab Consolidation in Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma","has_exemption":false,"start_date":"2019-01-02","completion_date":"2026-02-02","has_results":false,"results_due":false,"sponsor_name":"David Bond, MD","sponsor_slug":"david-bond-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04104893","publication_url":"https://clinicaltrials.gov/study/NCT04104893","title":"A Phase 2 Study of a Checkpoint Inhibitor in Men With Progressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation","has_exemption":false,"start_date":"2020-02-20","completion_date":"2026-02-02","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04547439","publication_url":"https://clinicaltrials.gov/study/NCT04547439","title":"Sleep and Circadian Regulation in Diabetic Retinopathy: The Role of Intrinsically Photosensitive Retinal Ganglion Cells and Melatonin Supplementation","has_exemption":false,"start_date":"2021-02-03","completion_date":"2026-02-02","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04586231","publication_url":"https://clinicaltrials.gov/study/NCT04586231","title":"An Open-label, Randomized, Phase 3 Study of MK-6482 in Combination With Lenvatinib (MK-7902) vs Cabozantinib in Participants With Advanced Renal Cell Carcinoma Who Have Progressed After Prior Anti-PD-1/L1 Therapy","has_exemption":false,"start_date":"2021-02-25","completion_date":"2026-02-02","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04760717","publication_url":"https://clinicaltrials.gov/study/NCT04760717","title":"Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke","has_exemption":false,"start_date":"2021-03-19","completion_date":"2026-02-02","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04708782","publication_url":"https://clinicaltrials.gov/study/NCT04708782","title":"A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)","has_exemption":false,"start_date":"2021-06-01","completion_date":"2026-02-02","has_results":false,"results_due":false,"sponsor_name":"United Therapeutics","sponsor_slug":"united-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04754425","publication_url":"https://clinicaltrials.gov/study/NCT04754425","title":"A Study of Erdafitinib in Castration-Resistant Prostate Cancer Patients Evaluating Markers of Bone Remodeling and FGF Signaling in Plasma and Bone Marrow","has_exemption":false,"start_date":"2021-07-15","completion_date":"2026-02-02","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05926960","publication_url":"https://clinicaltrials.gov/study/NCT05926960","title":"A PHASE 2, RANDOMIZED, OPEN-LABEL STUDY OF ENCORAFENIB AND BINIMETINIB PLUS PEMBROLIZUMAB VERSUS NIVOLUMAB AND IPILIMUMAB IN PARTICIPANTS WITH BRAF V600E/K MUTATION-POSITIVE MELANOMA WHO PROGRESSED DURING OR AFTER PRIOR TREATMENT WITH ANTI-PD-1 THERAPY","has_exemption":false,"start_date":"2023-06-13","completion_date":"2026-02-02","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06598059","publication_url":"https://clinicaltrials.gov/study/NCT06598059","title":"A Pivotal, Prospective, Multicentre, Single-arm Study Evaluating the Safety and Efficacy of a Dexamethasone Eluting Slim Modiolar Electrode Array (EA32D).","has_exemption":false,"start_date":"2025-01-03","completion_date":"2026-02-02","has_results":false,"results_due":false,"sponsor_name":"Cochlear","sponsor_slug":"cochlear","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02870738","publication_url":"https://clinicaltrials.gov/study/NCT02870738","title":"Comparison of Bladder Directed and Pelvic Floor Therapy in Women With Interstitial Cystitis/Bladder Pain Syndrome","has_exemption":false,"start_date":"2017-04-21","completion_date":"2026-02-03","has_results":false,"results_due":false,"sponsor_name":"Corewell Health East","sponsor_slug":"corewell-health-east","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04160052","publication_url":"https://clinicaltrials.gov/study/NCT04160052","title":"Phase I/II of Venetoclax in Combination With Azacitidine in Treatment Naïve and Relapse Refractory High Risk MDS Individuals\"","has_exemption":false,"start_date":"2019-10-01","completion_date":"2026-02-03","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04609566","publication_url":"https://clinicaltrials.gov/study/NCT04609566","title":"A Phase 2 Study of Brentuximab Vedotin in Combination With Pembrolizumab in Participants With Metastatic Solid Malignancies","has_exemption":false,"start_date":"2021-01-26","completion_date":"2026-02-03","has_results":false,"results_due":false,"sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","sponsor_slug":"seagen-a-wholly-owned-subsidiary-of-pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05524571","publication_url":"https://clinicaltrials.gov/study/NCT05524571","title":"A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants With Active Thyroid Eye Disease (TED)","has_exemption":false,"start_date":"2023-01-05","completion_date":"2026-02-03","has_results":false,"results_due":false,"sponsor_name":"Immunovant Sciences GmbH","sponsor_slug":"immunovant-sciences-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05592990","publication_url":"https://clinicaltrials.gov/study/NCT05592990","title":"A Two Part, Randomized, Participant and Investigator-blinded, 2-arm, Parallel-design, Placebo-controlled Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles on Tendon Regeneration in Patients With Achilles Tendinopathy","has_exemption":false,"start_date":"2023-06-14","completion_date":"2026-02-03","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06002152","publication_url":"https://clinicaltrials.gov/study/NCT06002152","title":"Superficial Cervical Plexus Block and Quality of Recovery After Thyroidectomy: A Randomized Controlled Trial","has_exemption":false,"start_date":"2023-11-27","completion_date":"2026-02-03","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02657486","publication_url":"https://clinicaltrials.gov/study/NCT02657486","title":"Pilot Study of BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder","has_exemption":false,"start_date":"2016-01-06","completion_date":"2026-02-04","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05171049","publication_url":"https://clinicaltrials.gov/study/NCT05171049","title":"A Multicenter, Randomized, Open-label, Blinded Endpoint Evaluation, Phase 3 Study Comparing the Effect of Abelacimab Relative to Apixaban on Venous Thromboembolism (VTE) Recurrence and Bleeding in Patients With Cancer Associated VTE","has_exemption":false,"start_date":"2022-05-05","completion_date":"2026-02-04","has_results":false,"results_due":false,"sponsor_name":"Anthos Therapeutics, Inc.","sponsor_slug":"anthos-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05411198","publication_url":"https://clinicaltrials.gov/study/NCT05411198","title":"A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of Ab Externo Implantation of Glaucoma Gel Stent","has_exemption":false,"start_date":"2022-07-22","completion_date":"2026-02-04","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06105541","publication_url":"https://clinicaltrials.gov/study/NCT06105541","title":"At-Home Transcutaneous Auricular Neuromodulation for Hypermobile Ehlers Danlos Syndrome","has_exemption":false,"start_date":"2023-07-05","completion_date":"2026-02-04","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06096337","publication_url":"https://clinicaltrials.gov/study/NCT06096337","title":"A Prospective Randomized Multicenter Global Study Comparing Pulsed Field Ablation (PFA) Versus Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation","has_exemption":false,"start_date":"2023-12-28","completion_date":"2026-02-04","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06529419","publication_url":"https://clinicaltrials.gov/study/NCT06529419","title":"A Phase 2b, Randomised, Double-Blind, Placebo-Controlled Dose Range-Finding Study to Assess Efficacy and Safety of Multiple Dose Levels of Inhaled AZD8630 Given Once Daily for 12 Weeks in Adults With Uncontrolled Asthma at Risk of Exacerbations (LEVANTE)","has_exemption":false,"start_date":"2024-08-30","completion_date":"2026-02-04","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06576427","publication_url":"https://clinicaltrials.gov/study/NCT06576427","title":"Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II","has_exemption":false,"start_date":"2024-10-15","completion_date":"2026-02-04","has_results":false,"results_due":false,"sponsor_name":"Jupiter Endovascular","sponsor_slug":"jupiter-endovascular","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01409200","publication_url":"https://clinicaltrials.gov/study/NCT01409200","title":"Pre-Surgical Androgen Deprivation Therapy With or Without Axitinib in Previously Untreated Prostate Cancer Patients With Known or Suspected Lymph Node Metastasis","has_exemption":false,"start_date":"2012-03-26","completion_date":"2026-02-05","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03581942","publication_url":"https://clinicaltrials.gov/study/NCT03581942","title":"Phase IB/II Study Combining the PI3K Inhibitor Copanlisib With the BTK Inhibitor Ibrutinib in Patients With Recurrent/Refractory Primary CNS Lymphoma","has_exemption":false,"start_date":"2018-08-23","completion_date":"2026-02-05","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05294588","publication_url":"https://clinicaltrials.gov/study/NCT05294588","title":"Division of Microbiology and Infectious Diseases, (DMID) 21-0018: Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae","has_exemption":false,"start_date":"2022-04-18","completion_date":"2026-02-05","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05583526","publication_url":"https://clinicaltrials.gov/study/NCT05583526","title":"A PHASE 3 RANDOMIZED, DOUBLE-BLIND, 52-WEEK PLACEBO-CONTROLLED, MULTI-CENTER STUDY INVESTIGATING THE EFFICACY, SAFETY, AND TOLERABILITY OF RITLECITINIB IN ADULT AND ADOLESCENT PARTICIPANTS WITH NON SEGMENTAL VITILIGO","has_exemption":false,"start_date":"2022-12-01","completion_date":"2026-02-05","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06181240","publication_url":"https://clinicaltrials.gov/study/NCT06181240","title":"Modification of Coronary Calcium With Laser Based Intravascular Lithotripsy for Coronary Artery Disease (FRACTURE)","has_exemption":false,"start_date":"2024-01-19","completion_date":"2026-02-05","has_results":false,"results_due":false,"sponsor_name":"Bolt Medical","sponsor_slug":"bolt-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06346288","publication_url":"https://clinicaltrials.gov/study/NCT06346288","title":"A Phase 4, Open-Label, Milk-Only Lactation Study to Assess Concentration of Risankizumab in Breast Milk of Lactating Women With Inflammatory Bowel Disease Who Are Receiving Risankizumab Therapeutically","has_exemption":false,"start_date":"2024-04-24","completion_date":"2026-02-05","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06605703","publication_url":"https://clinicaltrials.gov/study/NCT06605703","title":"The Comparative Effectiveness of Step-down Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide: A Randomized Controlled Trial (GLP1 Transition Trial)","has_exemption":false,"start_date":"2024-09-18","completion_date":"2026-02-05","has_results":false,"results_due":false,"sponsor_name":"WW International Inc","sponsor_slug":"ww-international-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07074704","publication_url":"https://clinicaltrials.gov/study/NCT07074704","title":"Transcranial Alternating Current Stimulation (tACS) as an Augmentation Treatment for Negative Symptoms and Cognitive Deficits in Long-term Hospitalized Schizophrenia Patients","has_exemption":false,"start_date":"2025-06-11","completion_date":"2026-02-05","has_results":false,"results_due":false,"sponsor_name":"Tongji University","sponsor_slug":"tongji-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06816004","publication_url":"https://clinicaltrials.gov/study/NCT06816004","title":"Noninvasive Vagal Nerve Stimulation for the Management of Symptoms Experienced in Multiple Sclerosis (VANISH-MS): An Open-Label Home-Based Study of taVNS and tcVNS Compared to tDCS","has_exemption":false,"start_date":"2025-08-20","completion_date":"2026-02-05","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03786354","publication_url":"https://clinicaltrials.gov/study/NCT03786354","title":"Prospective Evaluation of Shoulder Morbidity in Patients With Lymph-Node Positive Breast Cancer Receiving Regional Nodal Irradiation","has_exemption":false,"start_date":"2019-01-09","completion_date":"2026-02-06","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04624659","publication_url":"https://clinicaltrials.gov/study/NCT04624659","title":"An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral Etavopivat, a Pyruvate Kinase Activator in Patients With Sickle Cell Disease (HIBISCUS)","has_exemption":false,"start_date":"2021-01-29","completion_date":"2026-02-06","has_results":false,"results_due":false,"sponsor_name":"Forma Therapeutics, Inc.","sponsor_slug":"forma-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03988439","publication_url":"https://clinicaltrials.gov/study/NCT03988439","title":"A Phase 4, Open-Label, Multicenter Study Evaluating the Absorption and Systemic Pharmacokinetics and HPA Axis Suppression Potential of Topically Applied IDP-118 Lotion in Pediatric Subjects With Moderate to Severe Plaque Psoriasis","has_exemption":false,"start_date":"2021-03-24","completion_date":"2026-02-06","has_results":false,"results_due":false,"sponsor_name":"Bausch Health Americas, Inc.","sponsor_slug":"bausch-health-americas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05130177","publication_url":"https://clinicaltrials.gov/study/NCT05130177","title":"Phase II Study of PD-1 Inhibitor Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1 Relapsed/Refractory Melanoma","has_exemption":false,"start_date":"2022-03-16","completion_date":"2026-02-06","has_results":false,"results_due":false,"sponsor_name":"Diwakar Davar","sponsor_slug":"diwakar-davar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05754957","publication_url":"https://clinicaltrials.gov/study/NCT05754957","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled, Event-driven Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, After a Recent Acute Coronary Syndrome","has_exemption":false,"start_date":"2023-04-07","completion_date":"2026-02-06","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06088654","publication_url":"https://clinicaltrials.gov/study/NCT06088654","title":"A Phase 1/2, Open-Label, Multicenter Trial Investigating the Safety, Tolerability, and Preliminary Antineoplastic Activity of IPH6501 in Patients With Relapsed and/or Refractory CD20-expressing Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2024-03-04","completion_date":"2026-02-06","has_results":false,"results_due":false,"sponsor_name":"Innate Pharma","sponsor_slug":"innate-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06547086","publication_url":"https://clinicaltrials.gov/study/NCT06547086","title":"Rapid Eye Movement Restoration and Enhancement for Sleep-deprived Trauma-adaptation","has_exemption":false,"start_date":"2024-07-10","completion_date":"2026-02-06","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06624228","publication_url":"https://clinicaltrials.gov/study/NCT06624228","title":"A Multicenter, Randomized, Double-Blind, Risankizumab-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis","has_exemption":false,"start_date":"2024-10-21","completion_date":"2026-02-06","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07342426","publication_url":"https://clinicaltrials.gov/study/NCT07342426","title":"Comparison of the Effects of High and Low Dose High-intensity Laser Therapy in Patients With Lateral Epicondylitis","has_exemption":false,"start_date":"2026-01-12","completion_date":"2026-02-06","has_results":false,"results_due":false,"sponsor_name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","sponsor_slug":"kaohsiung-medical-university-chung-ho-memorial-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06354023","publication_url":"https://clinicaltrials.gov/study/NCT06354023","title":"Administration of Recombinant Human Growth Hormone in the Knee Joint of Patients Suffering from Osteoarthritis","has_exemption":false,"start_date":"2025-02-08","completion_date":"2026-02-08","has_results":false,"results_due":false,"sponsor_name":"John Sledge","sponsor_slug":"john-sledge","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04154111","publication_url":"https://clinicaltrials.gov/study/NCT04154111","title":"Theta Burst Stimulation as a Tool to Decrease Drinking in Treatment-seeking Alcohol Users","has_exemption":false,"start_date":"2020-05-26","completion_date":"2026-02-09","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04331041","publication_url":"https://clinicaltrials.gov/study/NCT04331041","title":"Phase II Study of Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma","has_exemption":false,"start_date":"2021-08-24","completion_date":"2026-02-09","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06100874","publication_url":"https://clinicaltrials.gov/study/NCT06100874","title":"A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)","has_exemption":false,"start_date":"2023-11-20","completion_date":"2026-02-09","has_results":false,"results_due":false,"sponsor_name":"Adrienne G. Waks","sponsor_slug":"adrienne-g-waks","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06367387","publication_url":"https://clinicaltrials.gov/study/NCT06367387","title":"Pain Self-Management and Patient-Oriented Dosing for Pain and Retention in Office-based Addiction Treatment: a Randomized Trial","has_exemption":false,"start_date":"2024-05-28","completion_date":"2026-02-09","has_results":false,"results_due":false,"sponsor_name":"Erin Winstanley","sponsor_slug":"erin-winstanley","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06046443","publication_url":"https://clinicaltrials.gov/study/NCT06046443","title":"A Randomized, Placebo-controlled, Double-Blind Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity, With an Open-Label Extension","has_exemption":false,"start_date":"2024-07-11","completion_date":"2026-02-09","has_results":false,"results_due":false,"sponsor_name":"Rhythm Pharmaceuticals, Inc.","sponsor_slug":"rhythm-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06531538","publication_url":"https://clinicaltrials.gov/study/NCT06531538","title":"A PHASE 2, RANDOMIZED, PARTIALLY DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE ADMINISTERED IN HEALTHY TODDLERS 12 THROUGH 15 MONTHS OF AGE","has_exemption":false,"start_date":"2024-07-30","completion_date":"2026-02-09","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06737042","publication_url":"https://clinicaltrials.gov/study/NCT06737042","title":"EFFICACY and SAFETY of GZR18 INJECTED EVERY 2 WEEKS (Q2W) in PARTICIPANTS WITHOUT TYPE 2 DIABETES, WHO HAVE OBESITY or ARE OVERWEIGHT: a RANDOMIZED, TIRZEPATIDE- and PLACEBO-CONTROLLED STUDY","has_exemption":false,"start_date":"2025-02-12","completion_date":"2026-02-09","has_results":false,"results_due":false,"sponsor_name":"Gan and Lee Pharmaceuticals, USA","sponsor_slug":"gan-and-lee-pharmaceuticals-usa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07445958","publication_url":"https://clinicaltrials.gov/study/NCT07445958","title":"In-Clinic Assessment of Vaginal Mucosal Safety Following Repetitive Use of the Livi Device","has_exemption":false,"start_date":"2026-01-28","completion_date":"2026-02-09","has_results":false,"results_due":false,"sponsor_name":"Atlantic Health System","sponsor_slug":"atlantic-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01247207","publication_url":"https://clinicaltrials.gov/study/NCT01247207","title":"An Open-Label, Safety Study for Ataluren (PTC124) Patients With Nonsense Mutation Dystrophinopathy","has_exemption":false,"start_date":"2010-11-30","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"PTC Therapeutics","sponsor_slug":"ptc-therapeutics","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01543659","publication_url":"https://clinicaltrials.gov/study/NCT01543659","title":"A Phase I/II Study of Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer","has_exemption":false,"start_date":"2012-02-21","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05776004","publication_url":"https://clinicaltrials.gov/study/NCT05776004","title":"A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of CAL02 Administered Intravenously in Addition to Standard of Care in Subjects With Severe Community-Acquired Bacterial Pneumonia (SCABP)","has_exemption":false,"start_date":"2023-07-22","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"Eagle Pharmaceuticals, Inc.","sponsor_slug":"eagle-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05798520","publication_url":"https://clinicaltrials.gov/study/NCT05798520","title":"A 2-Part, Multicenter, Randomized, Blinded, Active-Controlled Phase 2 Study to Sequentially Evaluate the Safety and Efficacy of BIIB091 Monotherapy and BIIB091 Combination Therapy With Diroximel Fumarate in Participants With Relapsing Forms of Multiple Sclerosis","has_exemption":false,"start_date":"2023-07-25","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06173791","publication_url":"https://clinicaltrials.gov/study/NCT06173791","title":"Demineralized Bone Allograft Fibers Versus Particulate In Sinus Augmentation: A Double Arm Randomized Control And Histomorphometric Study","has_exemption":false,"start_date":"2023-09-25","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06299826","publication_url":"https://clinicaltrials.gov/study/NCT06299826","title":"A Phase IIb Two-Cohort, Randomised, Placebo-controlled, Double-blind, Multi-centre, Dose-ranging Study of AZD5462 in Stable Patients With Chronic Heart Failure","has_exemption":false,"start_date":"2024-06-04","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06352372","publication_url":"https://clinicaltrials.gov/study/NCT06352372","title":"Safety and Efficacy of Transcranial Photobiomodulation (tPBM) for Individuals With Autism Spectrum Disorder and Epileptiform Activity","has_exemption":true,"start_date":"2024-07-01","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"Richard Frye","sponsor_slug":"richard-frye","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06787690","publication_url":"https://clinicaltrials.gov/study/NCT06787690","title":"A Prospective Multicenter Single-arm Clinical Study to Investigate Clinical Outcomes When Cohealyx™ is Used for the Management of Full Thickness Wounds Post-surgical Excision","has_exemption":false,"start_date":"2025-05-15","completion_date":"2026-02-10","has_results":false,"results_due":false,"sponsor_name":"Avita Medical","sponsor_slug":"avita-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05155605","publication_url":"https://clinicaltrials.gov/study/NCT05155605","title":"The PATHFINDER 2 Study: Evaluating the Safety and Performance of the GRAIL Multi-Cancer Early Detection Test in an Eligible Screening Population","has_exemption":false,"start_date":"2021-12-08","completion_date":"2026-02-11","has_results":false,"results_due":false,"sponsor_name":"GRAIL, Inc.","sponsor_slug":"grail-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05588843","publication_url":"https://clinicaltrials.gov/study/NCT05588843","title":"A Randomized, Double-blind, Placebo Controlled, Dose-finding Study to Assess the Efficacy and Safety of SAR443122 in Adult Patients With Moderate to Severe Ulcerative Colitis","has_exemption":false,"start_date":"2022-11-25","completion_date":"2026-02-11","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06435026","publication_url":"https://clinicaltrials.gov/study/NCT06435026","title":"Optimizing PrEP Regimens for Pregnant Women in Sub-Saharan Africa (O-PrEP Study) - Stage 1","has_exemption":false,"start_date":"2024-06-18","completion_date":"2026-02-11","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06488365","publication_url":"https://clinicaltrials.gov/study/NCT06488365","title":"In Vivo Liquid Biopsy for Early Detection of Metastatic Melanoma","has_exemption":false,"start_date":"2025-02-11","completion_date":"2026-02-11","has_results":false,"results_due":false,"sponsor_name":"Cytoastra","sponsor_slug":"cytoastra","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02875353","publication_url":"https://clinicaltrials.gov/study/NCT02875353","title":"Blood Flow Monitoring to Prevent Post-Polypectomy Induced Ulcer Bleeding","has_exemption":false,"start_date":"2017-02-15","completion_date":"2026-02-12","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05840159","publication_url":"https://clinicaltrials.gov/study/NCT05840159","title":"A Phase 4 Study of a 3-Day vs. 7-Day Regimen of Doxycycline for the Treatment of Chlamydial Infection","has_exemption":false,"start_date":"2024-01-19","completion_date":"2026-02-12","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06625411","publication_url":"https://clinicaltrials.gov/study/NCT06625411","title":"REVEAL-1 - A Phase 3, Randomized, Double-masked, Placebo-controlled, Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)","has_exemption":false,"start_date":"2024-08-27","completion_date":"2026-02-12","has_results":false,"results_due":false,"sponsor_name":"Viridian Therapeutics, Inc.","sponsor_slug":"viridian-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06685835","publication_url":"https://clinicaltrials.gov/study/NCT06685835","title":"A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa - The CEDAR Study","has_exemption":false,"start_date":"2024-12-16","completion_date":"2026-02-12","has_results":false,"results_due":false,"sponsor_name":"Insmed Incorporated","sponsor_slug":"insmed-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07290595","publication_url":"https://clinicaltrials.gov/study/NCT07290595","title":"Comparative Analysis Of Dexmedetomidine And Dexamethasone As An Adjuvant To 0.5%Ropivacaine On Onset Of Ultrasound Guided Supraclavicular Brachial Plexus Block In Patients Undergoing Upper Limb Surgeries","has_exemption":false,"start_date":"2025-01-13","completion_date":"2026-02-12","has_results":false,"results_due":false,"sponsor_name":"Sahiwal medical college sahiwal","sponsor_slug":"sahiwal-medical-college-sahiwal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06790121","publication_url":"https://clinicaltrials.gov/study/NCT06790121","title":"A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of 3 Subcutaneous Dose Regimens of Lunsekimig (SAR443765) in Adult Participants With Moderate-to-severe Atopic Dermatitis","has_exemption":false,"start_date":"2025-01-30","completion_date":"2026-02-12","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06932133","publication_url":"https://clinicaltrials.gov/study/NCT06932133","title":"Breast Point-of-Care Ultrasound Examination Trial","has_exemption":false,"start_date":"2025-04-07","completion_date":"2026-02-12","has_results":false,"results_due":false,"sponsor_name":"Region Skane","sponsor_slug":"region-skane","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04708834","publication_url":"https://clinicaltrials.gov/study/NCT04708834","title":"A Multicenter, Long-Term Open-Label Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder","has_exemption":false,"start_date":"2021-03-30","completion_date":"2026-02-13","has_results":false,"results_due":false,"sponsor_name":"Biohaven Pharmaceuticals, Inc.","sponsor_slug":"biohaven-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05016245","publication_url":"https://clinicaltrials.gov/study/NCT05016245","title":"A Multicentre, Prospective, Open-label, Randomized Controlled Trial on the Efficacy and Safety of TheraSphereTM (Yttrium-90 Glass Microspheres) Compared to Conventional Transarterial Chemoembolization (cTACE) in Chinese Patients With Inoperable Hepatocellular Carcinoma","has_exemption":false,"start_date":"2021-09-13","completion_date":"2026-02-13","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05018299","publication_url":"https://clinicaltrials.gov/study/NCT05018299","title":"A Randomized, Placebo Controlled, Double Blind Phase IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of Multiple Intravenous Doses of FB704A in Adults With Severe Asthma","has_exemption":false,"start_date":"2021-09-30","completion_date":"2026-02-13","has_results":false,"results_due":false,"sponsor_name":"Oneness Biotech Co., Ltd.","sponsor_slug":"oneness-biotech-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04582383","publication_url":"https://clinicaltrials.gov/study/NCT04582383","title":"A Randomized, Double-Blind, Multi-Center Comparative Effectiveness Study of Spironolactone Versus Doxycycline Hyclate for the Treatment of Acne in Women","has_exemption":false,"start_date":"2022-03-30","completion_date":"2026-02-13","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05220358","publication_url":"https://clinicaltrials.gov/study/NCT05220358","title":"Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study","has_exemption":false,"start_date":"2022-06-15","completion_date":"2026-02-13","has_results":false,"results_due":false,"sponsor_name":"Orlando Immunology Center","sponsor_slug":"orlando-immunology-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05317364","publication_url":"https://clinicaltrials.gov/study/NCT05317364","title":"Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery: a Randomized Clinical Trial","has_exemption":false,"start_date":"2022-07-14","completion_date":"2026-02-13","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06788535","publication_url":"https://clinicaltrials.gov/study/NCT06788535","title":"A Phase 3, Open-Label, Multicenter Study of I-124 Evuzamitide as an Imaging Agent for the Diagnosis of Cardiac Amyloidosis Using Positron Emission Tomography Computed Tomography (PET/CT)","has_exemption":false,"start_date":"2025-01-14","completion_date":"2026-02-13","has_results":false,"results_due":false,"sponsor_name":"Sharmila Dorbala","sponsor_slug":"sharmila-dorbala","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05149768","publication_url":"https://clinicaltrials.gov/study/NCT05149768","title":"An Open Label Extension Study of Brentuximab Vedotin Treatment in Active Diffuse Cutaneous Systemic Sclerosis (Diffuse Scleroderma)","has_exemption":false,"start_date":"2024-02-14","completion_date":"2026-02-14","has_results":false,"results_due":false,"sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","sponsor_slug":"london-health-sciences-centre-research-institute-or-lawson-research-institute-of-st-josephs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05127109","publication_url":"https://clinicaltrials.gov/study/NCT05127109","title":"The PASTDUe Nutrition EcoSystem Pathway In Acute Care Abdominal Surgery and Trauma to Decrease Underfeeding and Complications","has_exemption":false,"start_date":"2022-04-25","completion_date":"2026-02-15","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06439524","publication_url":"https://clinicaltrials.gov/study/NCT06439524","title":"The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial","has_exemption":false,"start_date":"2024-08-15","completion_date":"2026-02-15","has_results":false,"results_due":false,"sponsor_name":"Main Line Health","sponsor_slug":"main-line-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06549842","publication_url":"https://clinicaltrials.gov/study/NCT06549842","title":"Safe and Fast Radial Hemostasis Using Synergistic Strategies: SAFE & FAST Trial","has_exemption":false,"start_date":"2024-08-15","completion_date":"2026-02-15","has_results":false,"results_due":false,"sponsor_name":"Regional Hospital of Scranton","sponsor_slug":"regional-hospital-of-scranton","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06543303","publication_url":"https://clinicaltrials.gov/study/NCT06543303","title":"A Phase 2, Double-Masked, Randomized, Vehicle-controlled Trial Evaluating the Efficacy and Safety of Cevimeline Ophthalmic Solution Compared to Vehicle in Subjects With Dry Eye Disease","has_exemption":false,"start_date":"2024-12-31","completion_date":"2026-02-15","has_results":false,"results_due":false,"sponsor_name":"BioTheraVision, Inc.","sponsor_slug":"biotheravision-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06828666","publication_url":"https://clinicaltrials.gov/study/NCT06828666","title":"A Phase 1/2a, Multicenter, Randomized, Controlled, Single-Blind, Dose-Finding Study to Evaluate the Safety and Efficacy of Cryopreserved Devitalized Adipose Tissue Allograft (BRC-OA) for Pain Treatment in Subjects With Mild to Severe Osteoarthritis (OA) of the Knee","has_exemption":false,"start_date":"2025-05-05","completion_date":"2026-02-15","has_results":false,"results_due":false,"sponsor_name":"Britecyte","sponsor_slug":"britecyte","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07084363","publication_url":"https://clinicaltrials.gov/study/NCT07084363","title":"Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery (The QUANTUM Trial): Single-center Cluster Randomized Multiple Crossover Trial","has_exemption":false,"start_date":"2025-09-22","completion_date":"2026-02-15","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07148999","publication_url":"https://clinicaltrials.gov/study/NCT07148999","title":"An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for PPOS","has_exemption":false,"start_date":"2025-09-23","completion_date":"2026-02-15","has_results":false,"results_due":false,"sponsor_name":"Urmila DIwekar","sponsor_slug":"urmila-diwekar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219316","publication_url":"https://clinicaltrials.gov/study/NCT07219316","title":"Regenerative High Purity Type I Collagen Scaffold for Breast Cancer Excision Repair and Reconstruction: A Prospective Multicenter Clinical Trial","has_exemption":false,"start_date":"2025-10-15","completion_date":"2026-02-15","has_results":true,"results_due":false,"sponsor_name":"Adichunchanagiri Institute of Medical Sciences, B G Nagara","sponsor_slug":"adichunchanagiri-institute-of-medical-sciences-b-g-nagara","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT07344038","publication_url":"https://clinicaltrials.gov/study/NCT07344038","title":"Effectiveness of Bioceramic Calcium Silicate-based Pulpotomy Medicament on Primary Molars Restored With 3d Printed Resin Crowns (a Randomized Controlled Clinical Trial)","has_exemption":false,"start_date":"2026-01-20","completion_date":"2026-02-15","has_results":false,"results_due":false,"sponsor_name":"Alexandria University","sponsor_slug":"alexandria-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03066206","publication_url":"https://clinicaltrials.gov/study/NCT03066206","title":"A Phase II Study of Poziotinib in EGFR or HER2 Mutant Advanced Solid Tumors","has_exemption":false,"start_date":"2017-03-17","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03661320","publication_url":"https://clinicaltrials.gov/study/NCT03661320","title":"A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy Alone Versus Neoadjuvant Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post- Surgery Therapy With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle- Invasive Bladder Cancer","has_exemption":false,"start_date":"2018-11-06","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03875638","publication_url":"https://clinicaltrials.gov/study/NCT03875638","title":"Treating Hyperexcitability in Alzheimer's Disease With Levetiracetam to Improve Brain Function and Cognition","has_exemption":false,"start_date":"2019-08-22","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05628805","publication_url":"https://clinicaltrials.gov/study/NCT05628805","title":"Theta Burst Stimulation to Improve Inhibitory Motor Physiology in Tourette Syndrome","has_exemption":false,"start_date":"2022-11-01","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05910619","publication_url":"https://clinicaltrials.gov/study/NCT05910619","title":"Transcranial Pulse Stimulation of the Brain in Older Adults With and Without Mild Dementia","has_exemption":false,"start_date":"2024-02-16","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06314490","publication_url":"https://clinicaltrials.gov/study/NCT06314490","title":"Personalized Antisense Oligonucleotide Therapy for Rare Pediatric Genetic Disease: SCN2A","has_exemption":false,"start_date":"2024-02-16","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05621616","publication_url":"https://clinicaltrials.gov/study/NCT05621616","title":"A Phase 3, Open Label, Multicenter, Baseline-Controlled Sequential Dose Titration Study Followed by a Fixed Dose Observation Period to Evaluate Pharmacokinetics, Efficacy and Safety of Mirabegron Prolonged-Release Microgranula-Based Suspension in Children From 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor Overactivity","has_exemption":false,"start_date":"2024-02-28","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06721572","publication_url":"https://clinicaltrials.gov/study/NCT06721572","title":"Role of Home-Based Transcutaneous Electrical Acustimulation for Treatment of Pain in Patients With Chronic Pancreatitis (TEA-CuP): A Double-Blind, Sham-Controlled Crossover Trial","has_exemption":false,"start_date":"2025-01-13","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06844669","publication_url":"https://clinicaltrials.gov/study/NCT06844669","title":"HER2HEART-US: Primary Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy: a Pilot 2x2 Factorial Randomized Controlled Trial","has_exemption":false,"start_date":"2025-04-16","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07136766","publication_url":"https://clinicaltrials.gov/study/NCT07136766","title":"An 18 Week Study to Assess the Efficacy of a Test Product Used in Combination With a Currently Marketed Prescription Product","has_exemption":false,"start_date":"2025-09-10","completion_date":"2026-02-16","has_results":false,"results_due":false,"sponsor_name":"Good Molecules, LLC","sponsor_slug":"good-molecules-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06018558","publication_url":"https://clinicaltrials.gov/study/NCT06018558","title":"A Phase 1/2 Study to Assess the Safety And Efficacy Of OCU410 For Geographic Atrophy Secondary To Dry Age-Related Macular Degeneration","has_exemption":false,"start_date":"2023-02-23","completion_date":"2026-02-17","has_results":false,"results_due":false,"sponsor_name":"Ocugen","sponsor_slug":"ocugen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06162663","publication_url":"https://clinicaltrials.gov/study/NCT06162663","title":"Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors","has_exemption":false,"start_date":"2024-09-20","completion_date":"2026-02-17","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04350138","publication_url":"https://clinicaltrials.gov/study/NCT04350138","title":"A Phase II Randomized, Observer-Blind, Placebo-Controlled Study, to Assess the Efficacy of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) in Preventing Gonococcal Infection","has_exemption":false,"start_date":"2020-12-29","completion_date":"2026-02-18","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04821622","publication_url":"https://clinicaltrials.gov/study/NCT04821622","title":"TALAPRO-3: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, STUDY OF TALAZOPARIB WITH ENZALUTAMIDE VERSUS PLACEBO WITH ENZALUTAMIDE IN MEN WITH DDR GENE MUTATED METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER","has_exemption":false,"start_date":"2021-05-12","completion_date":"2026-02-18","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04965597","publication_url":"https://clinicaltrials.gov/study/NCT04965597","title":"Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for the Treatment of Bone Marrow Failure Diseases","has_exemption":false,"start_date":"2022-04-19","completion_date":"2026-02-18","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05831176","publication_url":"https://clinicaltrials.gov/study/NCT05831176","title":"A Phase 2, 2-Part, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis","has_exemption":false,"start_date":"2023-05-03","completion_date":"2026-02-18","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06569238","publication_url":"https://clinicaltrials.gov/study/NCT06569238","title":"The Role of the Microbiome in Diabetic Foot Ulcers","has_exemption":false,"start_date":"2024-09-05","completion_date":"2026-02-18","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06630559","publication_url":"https://clinicaltrials.gov/study/NCT06630559","title":"A Randomized, Active-Controlled, Double-Blind, Phase 3 Study to Compare Efficacy and Safety of CT-P55 With Cosentyx in Patients With Moderate to Severe Plaque Psoriasis","has_exemption":false,"start_date":"2025-05-26","completion_date":"2026-02-18","has_results":false,"results_due":false,"sponsor_name":"Celltrion","sponsor_slug":"celltrion","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04205838","publication_url":"https://clinicaltrials.gov/study/NCT04205838","title":"IL-1 Receptor Antagonist to Prevent Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome","has_exemption":false,"start_date":"2020-03-04","completion_date":"2026-02-19","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04471844","publication_url":"https://clinicaltrials.gov/study/NCT04471844","title":"EF-32: Pivotal, Randomized, Open-Label Study of Optune® (Tumor Treating Fields, 200kHz) Concomitant With Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma","has_exemption":false,"start_date":"2020-12-08","completion_date":"2026-02-19","has_results":false,"results_due":false,"sponsor_name":"NovoCure Ltd.","sponsor_slug":"novocure-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05848011","publication_url":"https://clinicaltrials.gov/study/NCT05848011","title":"A Phase 2, Randomized, Open-Label, Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer","has_exemption":false,"start_date":"2023-09-28","completion_date":"2026-02-19","has_results":false,"results_due":false,"sponsor_name":"MacroGenics","sponsor_slug":"macrogenics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06637072","publication_url":"https://clinicaltrials.gov/study/NCT06637072","title":"A Phase 4, Open-Label, Single-Group, Multicenter Study in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy Who Transition From Treatment With Intravenous Immunoglobulin to Efgartigimod PH20 SC","has_exemption":false,"start_date":"2024-12-10","completion_date":"2026-02-19","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03288545","publication_url":"https://clinicaltrials.gov/study/NCT03288545","title":"A Study of Enfortumab Vedotin (ASG-22CE) as Monotherapy or in Combination With Other Anticancer Therapies for the Treatment of Urothelial Cancer","has_exemption":false,"start_date":"2017-10-11","completion_date":"2026-02-20","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04562389","publication_url":"https://clinicaltrials.gov/study/NCT04562389","title":"A Phase 1/3 Study to Evaluate Efficacy and Safety of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Ruxolitinib in Treatment-naïve Patients With Myelofibrosis","has_exemption":false,"start_date":"2021-03-11","completion_date":"2026-02-20","has_results":false,"results_due":false,"sponsor_name":"Karyopharm Therapeutics Inc","sponsor_slug":"karyopharm-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04852783","publication_url":"https://clinicaltrials.gov/study/NCT04852783","title":"US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair","has_exemption":false,"start_date":"2021-08-06","completion_date":"2026-02-20","has_results":false,"results_due":false,"sponsor_name":"Cerus Endovascular, Inc.","sponsor_slug":"cerus-endovascular-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04820179","publication_url":"https://clinicaltrials.gov/study/NCT04820179","title":"Phase II Trial Evaluating the Safety and Efficacy of Atezolizumab in Combination With Cabozantinib for the Treatment of Metastatic, Refractory Pancreatic Cancer","has_exemption":false,"start_date":"2021-10-12","completion_date":"2026-02-20","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05648968","publication_url":"https://clinicaltrials.gov/study/NCT05648968","title":"A Phase 3, Randomized, Double-blind, Study to Assess Efficacy and Safety of Ianalumab (VAY736) Versus Placebo in Warm Autoimmune Hemolytic Anemia (wAIHA) Patients Who Failed at Least One Line of Treatment","has_exemption":false,"start_date":"2022-12-30","completion_date":"2026-02-20","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07178808","publication_url":"https://clinicaltrials.gov/study/NCT07178808","title":"PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER","has_exemption":false,"start_date":"2021-04-16","completion_date":"2026-02-22","has_results":false,"results_due":false,"sponsor_name":"Banner Health","sponsor_slug":"banner-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02719613","publication_url":"https://clinicaltrials.gov/study/NCT02719613","title":"Continuing Treatment for Subjects Who Have Participated in a Prior Protocol Investigating Elotuzumab","has_exemption":false,"start_date":"2016-07-15","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04974398","publication_url":"https://clinicaltrials.gov/study/NCT04974398","title":"A Randomized, Double-blind, Multi-center Phase III Study of Penpulimab (AK105) Combined With Chemotherapy Versus Placebo Combined With Chemotherapy in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma","has_exemption":false,"start_date":"2021-08-16","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"Akeso","sponsor_slug":"akeso","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05301842","publication_url":"https://clinicaltrials.gov/study/NCT05301842","title":"A Phase III, Randomized, Open-Label, Sponsor-Blinded, Multicenter Study of Durvalumab in Combination With Tremelimumab ± Lenvatinib Given Concurrently With TACE Compared to TACE Alone in Patients With Locoregional Hepatocellular Carcinoma (EMERALD-3)","has_exemption":false,"start_date":"2022-03-28","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05811351","publication_url":"https://clinicaltrials.gov/study/NCT05811351","title":"A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)","has_exemption":false,"start_date":"2023-03-06","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06102005","publication_url":"https://clinicaltrials.gov/study/NCT06102005","title":"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose Ranging Study to Assess the Efficacy, Safety, and Tolerability of Subcutaneous Lunsekimig in Adult Participants With Moderate-to-severe Asthma","has_exemption":false,"start_date":"2023-10-16","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06603077","publication_url":"https://clinicaltrials.gov/study/NCT06603077","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa (LOTUS)","has_exemption":false,"start_date":"2024-09-16","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"Avalo Therapeutics, Inc.","sponsor_slug":"avalo-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06836063","publication_url":"https://clinicaltrials.gov/study/NCT06836063","title":"A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial to Evaluate Efficacy and Safety of Ropanicant in Patients With Major Depressive Disorder","has_exemption":false,"start_date":"2025-07-15","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"Suven Life Sciences Limited","sponsor_slug":"suven-life-sciences-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06030193","publication_url":"https://clinicaltrials.gov/study/NCT06030193","title":"A Randomized, Active-controlled, Multi-site, Double-masked, Pilot Study to Evaluate the Safety and Tolerability of QLS-111 Versus Timolol Maleate Preservative Free 0.5% Ophthalmic Solution in Subjects With Normal Tension Glaucoma (NTG)","has_exemption":false,"start_date":"2025-08-13","completion_date":"2026-02-23","has_results":false,"results_due":false,"sponsor_name":"Qlaris Bio, Inc.","sponsor_slug":"qlaris-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04963283","publication_url":"https://clinicaltrials.gov/study/NCT04963283","title":"A Phase II Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer","has_exemption":false,"start_date":"2021-06-23","completion_date":"2026-02-24","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05598723","publication_url":"https://clinicaltrials.gov/study/NCT05598723","title":"A Randomized, Double-Blind Study on the Effect of OnabotulinumtoxinA (BOTOX®) vs. IncobotulinumtoxinA (XEOMIN®) Botulinum Toxin in Adults With Chronic Migraine","has_exemption":false,"start_date":"2023-02-24","completion_date":"2026-02-24","has_results":false,"results_due":false,"sponsor_name":"Naval Medical Center Camp Lejeune","sponsor_slug":"naval-medical-center-camp-lejeune","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06113445","publication_url":"https://clinicaltrials.gov/study/NCT06113445","title":"A Phase 3, Randomized, Double-Blind, 52-Week, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Nonsegmental Vitiligo","has_exemption":false,"start_date":"2023-11-29","completion_date":"2026-02-24","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06563102","publication_url":"https://clinicaltrials.gov/study/NCT06563102","title":"A 12-week, Randomized, Double-Blind, Phase 4 Study Evaluating the Effect of AIRSUPRA Compared to Albuterol Administered as Needed on Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization in Adults With Mild Asthma","has_exemption":false,"start_date":"2024-09-11","completion_date":"2026-02-24","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04016376","publication_url":"https://clinicaltrials.gov/study/NCT04016376","title":"Cluster-Randomized, Prospective Assessment of Postoperative Pain Management in Patients Undergoing Bilateral Mastectomy With Immediate Reconstruction With Tissue Expander (BMWRw/TE) Using Preoperative Paravertebral (PVB), Serratus+PECS-1, or PVB+PECS-1 Nerve Blocks","has_exemption":false,"start_date":"2019-07-05","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04039347","publication_url":"https://clinicaltrials.gov/study/NCT04039347","title":"A Phase III, Extension Clinical Trial to Demonstrate Efficacy and Safety of Liposomal Cyclosprine A Via the PARI Investigational eFlow® Device and SoC in Treating Bronchiolitis Obliterans in Patients Post Single or Double Lung Transplant","has_exemption":false,"start_date":"2020-03-12","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Zambon SpA","sponsor_slug":"zambon-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04343573","publication_url":"https://clinicaltrials.gov/study/NCT04343573","title":"A Phase II Randomized Study Assessing the Efficacy of Proton Craniospinal Irradiation (CSI) vs Involved-field Photon Radiation Therapy for Leptomeningeal Metastases From Solid Tumor Malignancies","has_exemption":false,"start_date":"2020-04-10","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04711148","publication_url":"https://clinicaltrials.gov/study/NCT04711148","title":"A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple Sclerosis to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Biological Activity","has_exemption":false,"start_date":"2021-03-01","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Beijing InnoCare Pharma Tech Co., Ltd.","sponsor_slug":"beijing-innocare-pharma-tech-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05348785","publication_url":"https://clinicaltrials.gov/study/NCT05348785","title":"A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants With Parkinson's Disease","has_exemption":false,"start_date":"2022-04-19","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05996835","publication_url":"https://clinicaltrials.gov/study/NCT05996835","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Four-arm, Parallel-group, Dose-finding Phase 2b Study to Investigate the Safety and Efficacy of TIN816 Via a Single Intravenous Infusion in the Treatment of Participants With Sepsis-associated Acute Kidney Injury (CLEAR-AKI)","has_exemption":false,"start_date":"2024-01-18","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07077044","publication_url":"https://clinicaltrials.gov/study/NCT07077044","title":"Transcutaneous Electrical Nerve Stimulation in Children With Functional Constipation Monitored by Pocket-sized Point-of-care Ultrasound.","has_exemption":false,"start_date":"2024-02-21","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Hadassah Medical Organization","sponsor_slug":"hadassah-medical-organization","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07120945","publication_url":"https://clinicaltrials.gov/study/NCT07120945","title":"A Prospective, Multicenter, Single-arm Pre-market Study of the Medtronic Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)","has_exemption":false,"start_date":"2025-08-28","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Medtronic - MITG","sponsor_slug":"medtronic-mitg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07058909","publication_url":"https://clinicaltrials.gov/study/NCT07058909","title":"Premarket Clinical Safety Assessment of the ELISIO™-HX","has_exemption":false,"start_date":"2025-09-08","completion_date":"2026-02-25","has_results":false,"results_due":false,"sponsor_name":"Nipro Medical Corporation","sponsor_slug":"nipro-medical-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02154568","publication_url":"https://clinicaltrials.gov/study/NCT02154568","title":"Flow Quantification in the Human Airways Using Hyperpolarized Helium 3 MRI","has_exemption":false,"start_date":"2013-11-07","completion_date":"2026-02-26","has_results":false,"results_due":false,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04785287","publication_url":"https://clinicaltrials.gov/study/NCT04785287","title":"Phase I/II Trial of Anti-CTLA4-NF mAb (BMS-986218) in Combination With Nivolumab and Hypofractionated Stereotactic Radiation Therapy in Patients With Advanced Solid Malignancies","has_exemption":false,"start_date":"2021-03-29","completion_date":"2026-02-26","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04709276","publication_url":"https://clinicaltrials.gov/study/NCT04709276","title":"A Phase II, Single Arm Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer (CHAMP)","has_exemption":false,"start_date":"2021-06-07","completion_date":"2026-02-26","has_results":false,"results_due":false,"sponsor_name":"Andrew J. Armstrong, MD","sponsor_slug":"andrew-j-armstrong-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05742802","publication_url":"https://clinicaltrials.gov/study/NCT05742802","title":"A Phase III, Multicentre, Randomised, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Extension Study to Evaluate the Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) With a History of Exacerbations (PROSPERO).","has_exemption":false,"start_date":"2023-03-06","completion_date":"2026-02-26","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05681884","publication_url":"https://clinicaltrials.gov/study/NCT05681884","title":"Faricimab for Retinal Non-Perfusion Associated With Non-Proliferative Diabetic Retinopathy: The MAGIC Phase 2, Multi-Center, Open-Label, Randomized Controlled Trial","has_exemption":false,"start_date":"2023-05-16","completion_date":"2026-02-26","has_results":false,"results_due":false,"sponsor_name":"Greater Houston Retina Research","sponsor_slug":"greater-houston-retina-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04777851","publication_url":"https://clinicaltrials.gov/study/NCT04777851","title":"A Phase III, Multicenter, Randomized, Open-label Trial to Evaluate the Safety and Efficacy of Systemic Therapy With Regorafenib and Pembrolizumab Versus Locoregional Therapy With Transarterial Chemoembolization or Transarterial Radioembolization, for the First-line Treatment of Intermediate-stage Hepatocellular Carcinoma With Beyond Up-to-7 Criteria","has_exemption":false,"start_date":"2023-10-11","completion_date":"2026-02-26","has_results":false,"results_due":false,"sponsor_name":"Translational Research in Oncology","sponsor_slug":"translational-research-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06130553","publication_url":"https://clinicaltrials.gov/study/NCT06130553","title":"PRIMROSE: A Modular Phase I/IIa, Multi-centre, Dose Escalation, and Expansion Study of AZD3470, a MTA Cooperative PRMT5 Inhibitor, as Monotherapy and in Combination With Anticancer Agents in Patients With Advanced/Metastatic Solid Tumors That Are MTAP Deficient","has_exemption":false,"start_date":"2024-01-18","completion_date":"2026-02-26","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06783621","publication_url":"https://clinicaltrials.gov/study/NCT06783621","title":"US HARMONY in DIVERSITY: A Prospective, Open-label Study to Evaluate Subject Satisfaction With the Overall Face and Neck Appearance After Combined Treatment","has_exemption":false,"start_date":"2025-01-16","completion_date":"2026-02-26","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03383458","publication_url":"https://clinicaltrials.gov/study/NCT03383458","title":"A Phase 3, Randomized, Double-blind Study of Adjuvant Nivolumab Versus Placebo for Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation","has_exemption":false,"start_date":"2018-04-18","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05230732","publication_url":"https://clinicaltrials.gov/study/NCT05230732","title":"Neuromodulation of Inflammation and Endothelial Function to Treat Elderly Patients With Systolic Heart Failure","has_exemption":false,"start_date":"2022-09-01","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05123040","publication_url":"https://clinicaltrials.gov/study/NCT05123040","title":"Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids for Treatment of Minnesota High-Risk Acute GVHD (aGVHD): A Phase I/II Study","has_exemption":false,"start_date":"2023-06-05","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06134648","publication_url":"https://clinicaltrials.gov/study/NCT06134648","title":"A Phase I/IIa, Randomized, Observer-blind Placebo-controlled Multi-arm Study to Evaluate the Safety and Immunogenicity of an RSV/hMPV Vaccine, in Adult Participants Aged 60 Years and Older","has_exemption":false,"start_date":"2023-11-01","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"Sanofi Pasteur, a Sanofi Company","sponsor_slug":"sanofi-pasteur-a-sanofi-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05982171","publication_url":"https://clinicaltrials.gov/study/NCT05982171","title":"Transcutaneous Spinal Cord Stimulation to Promote Walking Recovery After Spinal Cord Injury","has_exemption":false,"start_date":"2023-11-15","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"Craig Hospital","sponsor_slug":"craig-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06341712","publication_url":"https://clinicaltrials.gov/study/NCT06341712","title":"A Phase II, Randomized, Open-label Study to Assess the Efficacy, Safety, and Pharmacokinetics (PK) of Maintenance Cabozantinib (XL184) Plus Best Supportive Care (BSC) Versus BSC in Children, Adolescents and Young Adults (AYA) With Unresectable Residual Osteosarcoma Either at Diagnosis or at First Relapse After Standard Treatment","has_exemption":false,"start_date":"2024-11-22","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"Ipsen","sponsor_slug":"ipsen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06617338","publication_url":"https://clinicaltrials.gov/study/NCT06617338","title":"Native Alignment in the Setting of an Arthritic Knee in Total Knee Arthroplasty","has_exemption":false,"start_date":"2024-12-12","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06819033","publication_url":"https://clinicaltrials.gov/study/NCT06819033","title":"Effects of Photobiomodulation on Pain After Presentation of Aphthous Ulcers in Pediatric Dental Patients","has_exemption":false,"start_date":"2025-03-10","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06869187","publication_url":"https://clinicaltrials.gov/study/NCT06869187","title":"A Phase 2 Open-label Study of the Effect of Adjunctively Administered ABX-002 in Adults With Bipolar Disorder Experiencing an Episode of Depression","has_exemption":false,"start_date":"2025-03-28","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"Autobahn Therapeutics, Inc.","sponsor_slug":"autobahn-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06948760","publication_url":"https://clinicaltrials.gov/study/NCT06948760","title":"Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D [Launchpad Lyumjev]","has_exemption":false,"start_date":"2025-07-23","completion_date":"2026-02-27","has_results":false,"results_due":false,"sponsor_name":"Mark D. DeBoer, MD, MSc., MCR","sponsor_slug":"mark-d-deboer-md-msc-mcr","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03621553","publication_url":"https://clinicaltrials.gov/study/NCT03621553","title":"Vitamin D Homeostasis in Sarcoidosis","has_exemption":false,"start_date":"2010-07-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02560805","publication_url":"https://clinicaltrials.gov/study/NCT02560805","title":"Post-Traumatic Stress Disorder and Cardiovascular Disease Risk: Role of Sympathetic Overactivity and Angiotensin II","has_exemption":false,"start_date":"2015-10-31","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02735707","publication_url":"https://clinicaltrials.gov/study/NCT02735707","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","has_exemption":false,"start_date":"2016-04-11","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"UMC Utrecht","sponsor_slug":"umc-utrecht","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02481245","publication_url":"https://clinicaltrials.gov/study/NCT02481245","title":"A Pan-PPAR Agonist Treatment for Bipolar Depression: A Proof of Concept Study","has_exemption":false,"start_date":"2018-01-11","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04814355","publication_url":"https://clinicaltrials.gov/study/NCT04814355","title":"The Effect of Celecoxib on Neuroinflammation in MDD: PET Imaging of a Novel Treatment Target With [18F]FEPPA","has_exemption":false,"start_date":"2018-08-01","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Stony Brook University","sponsor_slug":"stony-brook-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03527472","publication_url":"https://clinicaltrials.gov/study/NCT03527472","title":"A Randomized Placebo-controlled, Double Blind Phase 2 Clinical Trial of Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2018-08-23","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03588754","publication_url":"https://clinicaltrials.gov/study/NCT03588754","title":"Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking?","has_exemption":false,"start_date":"2018-09-15","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03629340","publication_url":"https://clinicaltrials.gov/study/NCT03629340","title":"Phase II Trial of Metformin for Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction","has_exemption":false,"start_date":"2019-02-26","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03796559","publication_url":"https://clinicaltrials.gov/study/NCT03796559","title":"A Prospective Open Label Study of the Use of Magseed® Markers and Sentimag® to Localize Axillary Lymph Nodes with Biopsy-proven Metastases in Breast Cancer Patients","has_exemption":false,"start_date":"2019-06-13","completion_date":"2026-02-28","has_results":false,"results_due":false,"sponsor_name":"Endomagnetics Ltd.","sponsor_slug":"endomagnetics-ltd","status":"ongoing","is_pact":false,"days_late":null}]}